Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer's disease

Nature Neuroscience

Volumn 17, Issue 9, 2014, Pages 1164-1170

  Lunnon, Katie ^a   Smith, Rebecca ^b   Hannon, Eilis ^a   De Jager, Philip L ^c,d,e   Srivastava, Gyan ^c,e   Volta, Manuela ^b   Troakes, Claire ^b   Al Sarraj, Safa ^b   Burrage, Joe ^a   Macdonald, Ruby ^a   Condliffe, Daniel ^b   Harries, Lorna W ^a   Katsel, Pavel ^f   Haroutunian, Vahram ^f,g   Kaminsky, Zachary ^h,i   Joachim, Catharine ^j   Powell, John ^b   Lovestone, Simon ^b,k   Bennett, David A ^l   Schalkwyk, Leonard C ^b   Mill, Jonathan ^a,b   more..

^a UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^g Virginia Medical Center   (United States)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^j UNIVERSITY OF OXFORD   (United Kingdom)

^k WARNEFORD HOSPITAL   (United Kingdom)

^l RUSH UNIVERSITY MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANKYRIN; ANK1 PROTEIN, HUMAN; TRANSCRIPTOME;

ALZHEIMER DISEASE; ANKYRIN 1 GENE; ARTICLE; AUTOPSY; BLOOD ANALYSIS; BRAIN PROTECTION; CEREBELLUM; COHORT ANALYSIS; DNA METHYLATION; DNA METHYLATION ASSAY; ENTORHINAL CORTEX; GENE; GENE EXPRESSION PROFILING; GENOME-WIDE ASSOCIATION STUDY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; METHYLOMIC PROFILING; NERVE DEGENERATION; NEUROPATHOLOGY; NUCLEOTIDE SEQUENCE; PREFRONTAL CORTEX; PRIORITY JOURNAL; SUPERIOR TEMPORAL GYRUS; AGED; BRAIN CORTEX; FEMALE; GENETIC ASSOCIATION; GENETIC EPIGENESIS; GENETICS; MALE; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; TEMPORAL LOBE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANKYRINS; CEREBRAL CORTEX; DNA METHYLATION; ENTORHINAL CORTEX; EPIGENESIS, GENETIC; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; PREFRONTAL CORTEX; TEMPORAL LOBE; TRANSCRIPTOME;

EID: 84906716826     PISSN: 10976256     EISSN: 15461726     Source Type: Journal    
DOI: 10.1038/nn.3782     Document Type: Article

References (45)

1. Brookmeyer, R., Johnson, E., Ziegler-Graham, K. & Arrighi, H.M. Forecasting the global burden of Alzheimer's disease. Alzheimers Dement. 3, 186-191 (2007).
2. Knapp, M. & Prince, M. Dementia UK: the Full report. (Alzheimer's Society, 2007).
3. Hardy, J.A. & Higgins, G.A. Alzheimer's disease: the amyloid cascade hypothesis. Science 256, 184-185 (1992).
4. Hardy, J. & Selkoe, D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356 (2002).
5. Wenk, G.L. Neuropathologic changes in Alzheimer's disease. J. Clin. Psychiatry 64 (suppl. 9), 7-10 (2003).
6. Lambert, J.C. et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat. Genet. 45, 1452-1458 (2013).
7. Encode Project Consortium et al. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57-74 (2012).
8. Lunnon, K. & Mill, J. Epigenetic studies in Alzheimer's disease: current findings, caveats, and considerations for future studies. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 162B, 789-799 (2013).
9. Mill, J. & Heijmans, B.T. From promises to practical strategies in epigenetic epidemiology. Nat. Rev. Genet. 14, 585-594 (2013).
10. Murphy, T.M. & Mill, J. Epigenetics in health and disease: heralding the EWAS era. Lancet 383, 1952-1954 (2014).
11. Pidsley, R. et al. A data-driven approach to preprocessing Illumina 450K methylation array data. BMC Genomics 14, 293 (2013).
12. Braak, H. & Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239-259 (1991).
13. Kordeli, E. & Bennett, V. Distinct ankyrin isoforms at neuron cell bodies and nodes of Ranvier resolved using erythrocyte ankyrin-deficient mice. J. Cell Biol. 114, 1243-1259 (1991).
14. Boiko, T. et al. Ankyrin-dependent and -independent mechanisms orchestrate axonal compartmentalization of L1 family members neurofascin and L1/neuron-glia cell adhesion molecule. J. Neurosci. 27, 590-603 (2007).
15. Nelson, S.B., Janiesch, C. & Sander, M. Expression of Nkx6 genes in the hindbrain and gut of the developing mouse. J. Histochem. Cytochem. 53, 787-790 (2005).
16. Alanentalo, T. et al. Cloning and analysis of Nkx6.3 during CNS and gastrointestinal development. Gene Expr. Patterns 6, 162-170 (2006).
17. Guintivano, J., Aryee, M. & Kaminsky, Z. A cell epigenotype specific model for the correction of brain cellular heterogeneity bias and its application to age, brain region and major depression. Epigenetics 8, 290-302 (2013).
18. Pedersen, B.S., Schwartz, D.A., Yang, I.V. & Kechris, K.J. Comb-p: software for combining, analyzing, grouping and correcting spatially correlated P-values. Bioinformatics 28, 2986-2988 (2012).
19. Haroutunian, V. et al. Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease. Arch. Neurol. 55, 1185-1191 (1998).
20. Esiri, M.M. Brain banks: the Oxford experience. J. Neural Transm. Suppl. 39, 25-30 (1993).
21. De Jager, P.L. et al. Alzheimer's disease pathology is associated with early alterations in brain DNA methylation at ANK1, BIN1 and other loci. Nat. Neurosci. doi:10.1038/nn.3786 (17 August 2014).
22. Soranzo, N. et al. Common variants at 10 genomic loci influence hemoglobin A(1)(C) levels via glycemic and nonglycemic pathways. Diabetes 59, 3229-3239 (2010).
23. Imamura, M. et al. A single-nucleotide polymorphism in ANK1 is associated with susceptibility to type 2 diabetes in Japanese populations. Hum. Mol. Genet. 21, 3042-3049 (2012).
24. Harder, M.N. et al. Type 2 diabetes risk alleles near BCAR1 and in ANK1 associate with decreased beta-cell function whereas risk alleles near ANKRD55 and GRB14 associate with decreased insulin sensitivity in the Danish Inter99 cohort. J. Clin. Endocrinol. Metab. 98, E801-E806 (2013).
25. Barnes, D.E. & Yaffe, K. The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol. 10, 819-828 (2011).
26. Lovestone, S. Searching for biomarkers in neurodegeneration. Nat. Med. 16, 1371-1372 (2010).
27. Hooper, C., Lovestone, S. & Sainz-Fuertes, R. Alzheimer's disease, diagnosis and the need for biomarkers. Biomark. Insights 3, 317-323 (2008).
28. Fehlbaum-Beurdeley, P. et al. Toward an Alzheimer's disease diagnosis via high-resolution blood gene expression. Alzheimers Dement. 6, 25-38 (2010).
29. Rye, P.D. et al. A novel blood test for the early detection of Alzheimer's disease. J. Alzheimers Dis. 23, 121-129 (2011).
30. Booij, B.B. et al. A gene expression pattern in blood for the early detection of Alzheimer's disease. J. Alzheimers Dis. 23, 109-119 (2011).
31. Lunnon, K. et al. A blood gene expression marker of early Alzheimer's disease. J. Alzheimers Dis. 33, 737-753 (2013).
32. Fehlbaum-Beurdeley, P. et al. Validation of AclarusDx, a blood-based transcriptomic signature for the diagnosis of Alzheimer's disease. J. Alzheimers Dis. 32, 169-181 (2012).
33. Wu, Z.C. et al. Association of DAPK1 genetic variations with Alzheimer's disease in Han Chinese. Brain Res. 1374, 129-133 (2011).
34. Laumet, G. et al. Systematic analysis of candidate genes for Alzheimer's disease in a French, genome-wide association study. J. Alzheimers Dis. 20, 1181-1188 (2010).
35. Chapuis, J., Vingtdeux, V., Campagne, F., Davies, P. & Marambaud, P. Growth arrest-specific 1 binds to and controls the maturation and processing of the amyloid-beta precursor protein. Hum. Mol. Genet. 20, 2026-2036 (2011).
36. Lunnon, K. et al. Mitochondrial dysfunction and immune activation are detectable in early Alzheimer's disease blood. J. Alzheimers Dis. 30, 685-710 (2012).
37. Meaburn, E.L., Schalkwyk, L.C. & Mill, J. Allele-specific methylation in the human genome: implications for genetic studies of complex disease. Epigenetics 5, 578-582 (2010).
38. Shoemaker, R., Deng, J., Wang, W. & Zhang, K. Allele-specific methylation is prevalent and is contributed by CpG-SNPs in the human genome. Genome Res. 20, 883-889 (2010).
39. Davies, M.N. et al. Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood. Genome Biol. 13, R43 (2012).
40. Dempster, E.L. et al. Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder. Hum. Mol. Genet. 20, 4786-4796 (2011).
41. Wong, C.C. et al. Methylomic analysis of monozygotic twins discordant for autism spectrum disorder and related behavioural traits. Mol. Psychiatry 19, 495-503 (2014).
42. R Development Core Team. R: a language and environment for statistical computing. (R Foundation for Statistical Computing, Vienna, Austria, 2012).
43. Gentleman, R.C. et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5, R80 (2004).
44. Davis, S., Du, P., Bilke, S., Triche, J. & Bootwalla, M. Methylumi: Handle Illumina Methylation Data, v2.10.0 (R Graphic Manual, 2014).
45. Chen, Y.A. et al. Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray. Epigenetics 8, 203-209 (2013).